Literature DB >> 7901534

Epidemic of louse-borne relapsing fever in Ethiopia.

K O Sundnes1, A T Haimanot.   

Abstract

During summer 1991 an outbreak of louse-borne relapsing fever occurred simultaneously in two transit camps established for prisoners of war being returned from Eritrea at the end of the Ethiopian civil war. Only antibiotic treatment was given at the Bahr Dar camp where the frequency of cases increased for 20 days. Vector control by delousing in addition to antibiotics was given at Mekele camp where the frequency of cases fell over a similar period. This difference was significant (p < 0.001). Furthermore, there was a significant correlation between the decreasing proportion of camp inhabitants that had not been deloused at Mekele camp each day and the numbers of patients with fever (r = 0.89, p < 0.001). Taken together, these results confirm that effective control of an epidemic of louse-borne relapsing fever is dependent on efficient vector control in addition to antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901534     DOI: 10.1016/0140-6736(93)92190-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.

Authors:  T Meri; S J Cutler; A M Blom; S Meri; T S Jokiranta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.

Authors:  S F Porcella; S J Raffel; M E Schrumpf; M E Schriefer; D T Dennis; T G Schwan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

3.  Body lice as tools for diagnosis and surveillance of reemerging diseases.

Authors:  V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Markus M Simon; Reinhard Wallich
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

Review 5.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

6.  Louse-borne relapsing fever-A systematic review and analysis of the literature: Part 1-Epidemiology and diagnostic aspects.

Authors:  Pascal Kahlig; Daniel H Paris; Andreas Neumayr
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11

Review 7.  Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review.

Authors:  Jonathan A Polonsky; Sangeeta Bhatia; Keith Fraser; Arran Hamlet; Janetta Skarp; Isaac J Stopard; Stéphane Hugonnet; Laurent Kaiser; Christian Lengeler; Karl Blanchet; Paul Spiegel
Journal:  Infect Dis Poverty       Date:  2022-01-28       Impact factor: 4.520

8.  Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Peter Kraiczy; Peter F Zipfel; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.